Moderna

-$10.75 (-6.19%) Today
-$4.04 (-2.48%) As of 10:11 AM UTC after-hours

Why Robinhood?

You can buy or sell Moderna and other stocks, options, and ETFs commission-free!

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

CEO
Stéphane Bancel
Employees
1,300
Headquarters
Cambridge, Massachusetts
Founded
2010

MRNA Key Statistics

Market Cap
67.13B
Price-Earnings Ratio
Dividend Yield
Average Volume
13.80M
High Today
$180.70
Low Today
$156.89
Open Price
$178.30
Volume
18.91M
52 Week High
$189.26
52 Week Low
$46.13

MRNA News

Bloomberg11h

India Drugmaker Warning; Moderna Booster Effective: Virus Update

(Bloomberg) -- Indian drugmakers are warning that halting some cargo flights from China could disrupt the global drug supply chain. China supplies 60% to 70% of
MarketWatch14h

Moderna says trial booster vaccine effective against COVID-19 variants

Moderna Inc. MRNA, -6.19% stock rose more than 1% in the extended session Wednesday after the biotechnology company said that a single-dose booster COVID-19 vac
MarketWatchMay 4

Moderna to boost COVID-19 vaccine production at Massachusetts site by 50%

Shares of Moderna Inc. MRNA, +4.03% were down 0.3% in premarket trading on Tuesday after the company said it will double the size of its manufacturing space at

MRNA Earnings

-$0.69
$0.34
$1.36
$2.39
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$2.39 per share
Actual
Available May 6, Pre-Market
Preview Earnings Call

You May Also Like

SOLY

More MRNA News

BenzingaMay 3

Is Now The Time To Buy Stock In Vaxart Or Moderna?

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzing
ReutersMay 1

Japan to approve Moderna's COVID-19 vaccine as soon as May 21 - Yomiuri

Cargo boxes containing the first Japan-allocated batch of Moderna Inc.'s COVID-19 vaccine are unloaded from a Japan Airlines plane upon its arrival from Belgium
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure